Published in Int J Neuropsychopharmacol on September 21, 2016
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science (2006) 9.31
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci (2006) 8.24
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem (1999) 7.94
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci (2002) 5.17
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov (2005) 3.80
The economic cost of brain disorders in Europe. Eur J Neurol (2012) 3.53
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci (1997) 3.41
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci (1996) 3.33
Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J (1990) 2.77
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci (2006) 2.75
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol (2010) 2.64
K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene (1992) 2.20
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry (2007) 2.01
cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci (2000) 1.86
Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res (1976) 1.77
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res (2005) 1.76
The role of CREB in depression and antidepressant treatment. Biol Psychiatry (2006) 1.59
The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation. J Neurochem (1965) 1.58
Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry (2014) 1.54
Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep (2009) 1.44
Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci U S A (2005) 1.43
Pathobiological targets of depression. Expert Opin Ther Targets (2011) 1.42
Animal models of mood disorders: Recent developments. Curr Opin Psychiatry (2007) 1.38
Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. J Neurosci (2009) 1.29
Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav (2007) 1.28
Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci U S A (1995) 1.25
Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Science (1992) 1.22
Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc Natl Acad Sci U S A (1988) 1.21
Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. Am J Psychiatry (2006) 1.17
Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci U S A (2012) 1.17
Gangliosides in isolated neurons and glial cells. Science (1967) 1.16
How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol (2001) 1.16
Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci (2005) 1.13
Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res (2008) 1.13
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr Neuropharmacol (2006) 1.07
A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients. J Neurol Sci (2012) 1.05
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry (2013) 1.04
GM1 ganglioside in Parkinson's disease: Results of a five year open study. J Neurol Sci (2010) 1.02
GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J Neurochem (2002) 0.99
Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1. J Neurosci (2010) 0.98
Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin Investig Drugs (2011) 0.95
A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress. Genes Brain Behav (2011) 0.92
Gangliosides determine the amyloid pathology of Alzheimer's disease. Neuroreport (2009) 0.91
Composition of gangliosides from human brain. Nature (1956) 0.91
The neurobiology of postpartum depression. CNS Spectr (2005) 0.89
Fuzi polysaccharide-1 produces antidepressant-like effects in mice. Int J Neuropsychopharmacol (2009) 0.89
Gangliosides activate Trk receptors by inducing the release of neurotrophins. J Biol Chem (2002) 0.88
Exogenous gangliosides increase the release of brain-derived neurotrophic factor. Neuropharmacology (2010) 0.84
Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease. Neurol Sci (2012) 0.84
GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J Neurochem (1998) 0.84
Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo. J Neurosci Res (1984) 0.83
Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain. Brain Res (1986) 0.82
Influence of endogenous GM1 ganglioside on TrkB activity, in cultured neurons. FEBS Lett (1998) 0.82
GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors. J Neurochem (2007) 0.79
Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: insights and speculations regarding a common mechanism. Perspect Dev Neurobiol (1996) 0.79
Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J Neurochem (1988) 0.79
The Possible Damaged Mechanism and the Preventive Effect of Monosialotetrahexosylganglioside in a Rat Model of Cerebral Ischemia-Reperfusion Injury. J Stroke Cerebrovasc Dis (2015) 0.78
GM1 ganglioside activates ERK1/2 and Akt downstream of Trk tyrosine kinase and protects PC12 cells against hydrogen peroxide toxicity. Neurochem Res (2014) 0.78
WY14643 produces anti-depressant-like effects in mice via the BDNF signaling pathway. Psychopharmacology (Berl) (2014) 0.78
Tetramethylpyrazine Produces Antidepressant-Like Effects in Mice Through Promotion of BDNF Signaling Pathway. Int J Neuropsychopharmacol (2015) 0.77
Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N,N-dimethyltryptamine. Brain Res Bull (1996) 0.77
Promotion of neuronal survival by GM1 ganglioside. Phenomenology and mechanism of action. Ann N Y Acad Sci (1998) 0.77
Gangliosides enhance behavioral and neurochemical effects induced by chronic desipramine (DMI) treatment. Eur J Pharmacol (1989) 0.76
Exogenous GM1 ganglioside increases accumbal BDNF levels in rats. Behav Brain Res (2014) 0.76
Gangliosides enhance the anti-immobility response elicited by several antidepressant treatments in mice. Psychopharmacology (Berl) (1990) 0.76